BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2024 10:41:21 AM | Browse: 75 | Download: 235
 |
Received |
|
2024-03-03 14:15 |
 |
Peer-Review Started |
|
2024-03-03 14:15 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-04-24 02:26 |
 |
Revised |
|
2024-05-07 03:24 |
 |
Second Decision |
|
2024-05-28 02:44 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-05-28 05:52 |
 |
Articles in Press |
|
2024-05-28 05:52 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-06-01 01:14 |
 |
Typeset the Manuscript |
|
2024-06-04 05:51 |
 |
Publish the Manuscript Online |
|
2024-06-25 10:41 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Noncommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Medicine, General & Internal |
Manuscript Type |
Editorial |
Article Title |
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
|
Manuscript Source |
Invited Manuscript |
All Author List |
Amedeo Lonardo |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Amedeo Lonardo, MD, Academic Research, Doctor, Doctor, Professor, Senior Lecturer, Department of Internal Medicine, Azienda Ospedaliero-Universitaria of Modena (2023), Ospedale Baggiovara, 41121 Modena, Modena 41126, Italy. a.lonardo@libero.it |
Key Words |
Alanine aminotransferase; Biomarker; History of medicine; Metabolic dysfunction-associated fatty liver disease; Metabolism; Nonalcoholic fatty liver disease; Reference range; Sex differences; Steatotic liver disease |
Core Tip |
The recent paper published by Chen et al. (Chen JF, et al. World Journal of Gastroenterology doi: 10.3748/wjg.v30.i10.1346) has two main findings. First, > 80% of individuals with metabolic dysfunction-associated fatty liver disease (MAFLD) had normal alanine aminotransferase (ALT) levels. Second, there was a linear increasing trend in the association between cumulative excess high-normal ALT levels and the rate of incident MAFLD. Future studies on steatotic liver disease owing to metabolic dysfunction should adopt locally determined and prospectively validated reference ranges of ALT and carefully consider sex differences in liver enzymes and pathobiology of MAFLD. The recent paper published by Chen et al. (Chen JF, et al. World Journal of Gastroenterology doi: 10.3748/wjg.v30.i10.1346) has two main findings. First, > 80% of individuals with metabolic dysfunction-associated fatty liver disease (MAFLD) had normal alanine aminotransferase (ALT) levels. Second, there was a linear increasing trend in the association between cumulative excess high-normal ALT levels and the rate of incident MAFLD. Future studies on steatotic liver disease owing to metabolic dysfunction should adopt locally determined and prospectively validated reference ranges of ALT and carefully consider sex differences in liver enzymes and pathobiology of MAFLD. |
Publish Date |
2024-06-25 10:41 |
Citation |
<p>Lonardo A. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker ! . <i>World J Gastroenterol</i> 2024; 30(24): 3016-3021</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i24/3016.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i24.3016 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345